RxDoctor Payments Data

Tara Tait, PA

Physician Assistant · Andover, MNNPI 1912456062

Payments from drug & device makers

$602in general payments, 2019–2025

Across 37 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$83
  • Alkermes, Inc.$71
  • Neurocrine Biosciences, Inc.$56
  • Almatica Pharma LLC$46
  • Supernus Pharmaceuticals, Inc.$38
  • Indivior Inc.$37
  • plus $271 from 13 others

What the payments were for

  • Food & beverage$602100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$602 in reported general payments places this provider in the 85th percentile of 3,121 physician assistant providers in Minnesota.

See all physician assistant providers in Minnesota

Medicare billing

Part B allowed, 2024
$48,060
Medicare patients
77
Services billed
528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate20$169,694
Invega SustennaPaliperidone Palmitate37$110,625
RexultiBrexpiprazole44$65,531
VraylarCariprazine Hcl41$61,060
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl104$25,608
SuboxoneBuprenorphine Hcl/Naloxone Hcl49$18,411
Olanzapine235$12,576
Lurasidone Hcl47$12,327
BelsomraSuvorexant12$10,249
Aripiprazole230$9,825
TrintellixVortioxetine Hydrobromide13$9,157
Clozapine102$8,511
VyvanseLisdexamfetamine Dimesylate22$8,488
Quetiapine Fumarate217$8,076
Divalproex Sodium ErDivalproex Sodium137$7,424

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$56$169,69420 claims
Johnson & JohnsonInvega Sustenna$24$110,62537 claims
Otsuka America Pharmaceutical, Inc.Rexulti$29$65,53144 claims
Indivior Inc.Suboxone$37$18,41149 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$31$17,64535 claims
Almatica Pharma LLCSertraline Hcl$46$2,189146 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,121 physician assistant providers in Minnesota.

Other physician assistant in Andover

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →